Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (71-80 of 280) with videos related to

Pageof 28
Sort By:
Cancers|November 14, 2019
The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid LeukemiaArne Velthaus, Kerstin Cornils, Jan K Hennigs, et al.
Cancers|November 27, 2024
Dose-Reduced FLA-IDA in Combination with Venetoclax Is an Effective and Safe Salvage Therapy in Relapsed and Refractory Acute Myeloid Leukemia (R/R AML)Martin Schönrock, Piet Sonnemann, Nina Michalowski, et al.
Experimental Hematology|September 14, 2016
MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia developmentEdith Schneider, Anna Staffas, Linda Röhner, et al.
Haematologica|October 29, 2017
Chromothripsis is linked to <i>TP53</i> alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotypeFrank G Rücker, Anna Dolnik, Tamara J Blätte, et al.
European Journal of Haematology|August 26, 2019
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutationDaniele Mannina, Nico Gagelmann, Anita Badbaran, et al.
BMC Genomics|September 13, 2014
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotypeSimone Feurstein, Frank G Rücker, Lars Bullinger, et al.
Oncotarget|November 2, 2017
Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapyMin Yang, Zengkai Pan, Kezhi Huang, et al.
Viruses|August 10, 2021
Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123Michael A Morgan, Arnold Kloos, Daniela Lenz, et al.
Frontiers in Immunology|October 23, 2018
Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK SubsetStephan Kloess, Alessa Ede Valverde da Silva, Olaf Oberschmidt, et al.
Frontiers in Immunology|September 26, 2017
Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK SubsetStephan Kloess, Alessa Ede Valverde da Silva, Olaf Oberschmidt, et al.
Pageof 28

Showing results (71-80 of 280) with videos related to

Sort By:
Pageof 28
Cancers|November 14, 2019
The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid LeukemiaArne Velthaus, Kerstin Cornils, Jan K Hennigs, et al.
Cancers|November 27, 2024
Dose-Reduced FLA-IDA in Combination with Venetoclax Is an Effective and Safe Salvage Therapy in Relapsed and Refractory Acute Myeloid Leukemia (R/R AML)Martin Schönrock, Piet Sonnemann, Nina Michalowski, et al.
Experimental Hematology|September 14, 2016
MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia developmentEdith Schneider, Anna Staffas, Linda Röhner, et al.
Haematologica|October 29, 2017
Chromothripsis is linked to <i>TP53</i> alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotypeFrank G Rücker, Anna Dolnik, Tamara J Blätte, et al.
European Journal of Haematology|August 26, 2019
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutationDaniele Mannina, Nico Gagelmann, Anita Badbaran, et al.
BMC Genomics|September 13, 2014
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotypeSimone Feurstein, Frank G Rücker, Lars Bullinger, et al.
Oncotarget|November 2, 2017
Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapyMin Yang, Zengkai Pan, Kezhi Huang, et al.
Viruses|August 10, 2021
Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123Michael A Morgan, Arnold Kloos, Daniela Lenz, et al.
Frontiers in Immunology|October 23, 2018
Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK SubsetStephan Kloess, Alessa Ede Valverde da Silva, Olaf Oberschmidt, et al.
Frontiers in Immunology|September 26, 2017
Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK SubsetStephan Kloess, Alessa Ede Valverde da Silva, Olaf Oberschmidt, et al.
Pageof 28